Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.
about
Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer.Regulatory functional territory of PLK-1 and their substrates beyond mitosis.Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate CancerThe role of Plk3 in oncogenesis.Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma.Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer.Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer.Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.Low-dose arsenic-mediated metabolic shift is associated with activation of Polo-like kinase 1 (Plk1).Maf1, A New PTEN Target Linking RNA and Lipid Metabolism.Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer.PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy.PTEN regulates PLK1 and controls chromosomal stability during cell divisionPlk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation.Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice.Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway.The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.Functional Effects of AKT3 on Aurora Kinase Inhibitor-induced Aneuploidy.PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation.miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.promotes gastric epithelial cell survival through the PLK1/PI3K/Akt pathway
P2860
Q30276399-BDA637E7-526F-4963-9630-45CAA783E776Q33914204-D961A243-DF49-45AF-A56F-9B23BCFD71F5Q34042731-39FF36EE-3C78-4632-B956-7E69CC74B8ACQ36289531-96B75C8A-C14F-4884-BE95-216604768223Q38444150-28621B47-E1DA-403C-B171-FE3E6E536D0EQ38714999-937022EE-373E-4D6E-8B90-D964E99BE6F6Q38792069-A7C069C2-924D-45A3-AA22-FCA537B191B9Q38793115-A855037A-DCC0-4CFF-A596-5E3555B313D5Q38823123-666A6792-05A6-4535-8F96-276833DF4597Q38842267-7B5B024F-CD60-4471-9B16-01497C8069AFQ38863765-71B86311-D859-4701-A0DF-6A5B426FA137Q38872725-ACB8A4D1-2EF2-4441-B87A-9BE61BDBAD20Q38953636-D76E8DC2-7EB6-4CC8-BAEF-067229AC5376Q39012724-D32A0D67-DC9F-4AA3-AF4A-482248EDFA3AQ39615345-99B74D90-9AA5-4E00-9957-528BE81EEF57Q42413368-D760F8F9-3657-46F6-95DD-69324C1D0730Q42777655-7F06D9E4-22BC-4A85-8E44-D4CBD3F3B376Q44105853-CF1663EF-9733-4053-8DB5-1A50C9FE6A5FQ45068538-DFDAC7C8-9E67-4A6D-809B-35CA0E9D9E0DQ48231954-B916B9FD-039A-43E2-9DCA-CDD9C64F434AQ49279696-A1E974C3-1AAA-451F-9255-9272A32496FDQ50168053-AFEB5364-746D-4599-9DF8-1BBEC865AAC7Q54977356-ACB0A75F-C9DB-4F28-B002-65A3FA6373B0Q58751038-3C56759B-97F6-4B3F-95D2-24DBD81DCD73
P2860
Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.
@en
type
label
Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.
@en
prefLabel
Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.
@en
P2093
P2860
P356
P1476
Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
@en
P2093
Bennett D Elzey
Grant Burcham
Nihal Ahmad
Stephen F Konieczny
Timothy Ratliff
Xiaoqi Liu
P2860
P304
P356
10.1128/MCB.00814-14
P407
P577
2014-07-21T00:00:00Z